159 related articles for article (PubMed ID: 23017618)
1. Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial.
Nuñez GR; Pinczowski H; Zanellato R; Tateyama L; Schindler F; Fonseca F; Del Giglio A
J Pain Symptom Manage; 2013 Jun; 45(6):969-79. PubMed ID: 23017618
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
3. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
Lipov EG; Joshi JR; Sanders S; Wilcox K; Lipov S; Xie H; Maganini R; Slavin K
Lancet Oncol; 2008 Jun; 9(6):523-32. PubMed ID: 18485819
[TBL] [Abstract][Full Text] [Related]
4. Pilot evaluation of bupropion for the treatment of hot flashes.
Pérez DG; Loprinzi CL; Sloan J; Novotny P; Barton D; Carpenter L; Smith D; Christensen B; Rummans T
J Palliat Med; 2006 Jun; 9(3):631-7. PubMed ID: 16752968
[TBL] [Abstract][Full Text] [Related]
5. A comparison of sustained-release bupropion and placebo for smoking cessation.
Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
[TBL] [Abstract][Full Text] [Related]
6. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
7. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
[TBL] [Abstract][Full Text] [Related]
8. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.
Gordon PR; Kerwin JP; Boesen KG; Senf J
Menopause; 2006; 13(4):568-75. PubMed ID: 16837878
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S;
Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399
[TBL] [Abstract][Full Text] [Related]
10. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
[TBL] [Abstract][Full Text] [Related]
11. A bupropion smoking cessation clinical trial for cancer patients.
Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
[TBL] [Abstract][Full Text] [Related]
12. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
13. Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial.
Mao JJ; Bowman MA; Xie SX; Bruner D; DeMichele A; Farrar JT
J Clin Oncol; 2015 Nov; 33(31):3615-20. PubMed ID: 26304905
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
15. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners.
Moss EL; Simpson JS; Pelletier G; Forsyth P
Psychooncology; 2006 Mar; 15(3):259-67. PubMed ID: 16041840
[TBL] [Abstract][Full Text] [Related]
16. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial.
Biglia N; Kubatzki F; Sgandurra P; Ponzone R; Marenco D; Peano E; Sismondi P
Breast J; 2007; 13(5):490-5. PubMed ID: 17760671
[TBL] [Abstract][Full Text] [Related]
18. Bupropion and restless legs syndrome: a randomized controlled trial.
Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
[TBL] [Abstract][Full Text] [Related]
20. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial.
Auerbach L; Rakus J; Bauer C; Gerner C; Ullmann R; Wimmer H; Huber J
Menopause; 2012 Apr; 19(4):426-32. PubMed ID: 22240636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
